Skip to main content
SpringerLink
Log in

Movement Disorders: Viewpoint—Medical Therapy

  • Chapter
Principles and Practice of Stereotactic Radiosurgery

  • 2558 Accesses

Abstract

The field of movement disorders is discussed with reference to the two most common disorders: Parkinson disease and essential tremor; the similarities and differences between the two disorders are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Parkinson J. An essay on the shaking palsy. J Neuropsychiatry Clin Neurosci. 2002;14(2):223–36.

    Article  PubMed  Google Scholar 

  2. Uitti RJ, Baba Y, Whaley NR, Wszolek ZK, Putzke JD. Parkinson disease: Handedness predicts asymmetry. Neurology. 2005;64(11): 1925–30.

    Article  CAS  PubMed  Google Scholar 

  3. Gomez-Esteban JC, Tijero B, Ciordia R, Berganzo K, Somme J, Lezcano E, et al. Factors influencing the symmetry of Parkinson’s disease symptoms. Clin Neurol Neurosurg. 2010;112(4):302–5.

    Article  PubMed  Google Scholar 

  4. Siderowf A, Lang AE. Premotor Parkinson’s disease: concepts and definitions. Mov Disord. 2012;27(5):608–16.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  5. Postuma RB, Aarsland D, Barone P, Burn DJ, Hawkes CH, Oertel W, et al. Identifying prodromal Parkinson’s disease: pre-motor disorders in Parkinson’s disease. Mov Disord. 2012;27(5):617–26.

    Article  PubMed  Google Scholar 

  6. Doty RL, Stern MB, Pfeiffer C, Gollomp SM, Hurtig HI. Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry. 1992;55(2): 138–42.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  7. Iranzo A, Molinuevo JL, Santamaria J, Serradell M, Marti MJ, Valldeoriola F, et al. Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study. Lancet Neurol. 2006;5(7):572–7.

    Article  PubMed  Google Scholar 

  8. Jellinger KA. Neuropathology of sporadic Parkinson’s disease: evaluation and changes of concepts. Mov Disord. 2012;27(1): 8–30.

    Article  CAS  PubMed  Google Scholar 

  9. Djaldetti R, Lorberboym M, Karmon Y, Treves TA, Ziv I, Melamed E. Residual striatal dopaminergic nerve terminals in very long-standing Parkinson’s disease: a single photon emission computed tomography imaging study. Mov Disord. 2011;26(2):327–30.

    Article  PubMed  Google Scholar 

  10. Parkinson Study Group. A controlled, randomized, delayed-start study of rasagiline in early Parkinson disease. Arch Neurol. 2004; 61(4):561–6.

    Article  Google Scholar 

  11. Olanow CW, Rascol O, Hauser R, Feigin PD, Jankovic J, Lang A, et al. A double-blind, delayed-start trial of rasagiline in Parkinson’s disease. N Engl J Med. 2009;361(13):1268–78.

    Article  CAS  PubMed  Google Scholar 

  12. Lees A. Alternatives to levodopa in the initial treatment of early Parkinson’s disease. Drugs Aging. 2005;22(9):731–40.

    Article  CAS  PubMed  Google Scholar 

  13. Jankovic J, Stacy M. Medical management of levodopa-associated motor complications in patients with Parkinson’s disease. CNS Drugs. 2007;21(8):677–92.

    Article  CAS  PubMed  Google Scholar 

  14. Pahwa R, Lyons KE. Levodopa-related wearing-off in Parkinson’s disease: identification and management. Curr Med Res Opin. 2009; 25(4):841–9.

    Article  CAS  PubMed  Google Scholar 

  15. Bayulkem K, Lopez G. Clinical approach to nonmotor sensory fluctuations in Parkinson’s disease. J Neurol Sci. 2011;310(1–2):82–5.

    Article  PubMed  Google Scholar 

  16. Busenbark KL, Nash J, Nash S, Hubble JP, Koller WC. Is essential tremor benign? Neurology. 1991;41(12):1982–3.

    Article  CAS  PubMed  Google Scholar 

  17. Teive HA. Essential tremor: phenotypes. Parkinsonism Relat Disord. 2012;18 Suppl 1:S140–2 [Review].

    Article  PubMed  Google Scholar 

  18. Troster AI, Woods SP, Fields JA, Lyons KE, Pahwa R, Higginson CI, et al. Neuropsychological deficits in essential tremor: an expression of cerebello-thalamo-cortical pathophysiology? Eur J Neurol. 2002;9(2):143–51.

    Article  CAS  PubMed  Google Scholar 

  19. Louis ED, Benito-Leon J, Bermejo-Pareja F. Self-reported depression and anti-depressant medication use in essential tremor: cross-sectional and prospective analyses in a population-based study. Eur J Neurol. 2007;14(10):1138–46.

    Article  CAS  PubMed  Google Scholar 

  20. Lorenz D, Schwieger D, Moises H, Deuschl G. Quality of life and personality in essential tremor patients. Mov Disord. 2006;21(8):1114–8.

    Article  PubMed  Google Scholar 

  21. Lyons KE, Pahwa R. Pharmacotherapy of essential tremor : an overview of existing and upcoming agents. CNS Drugs. 2008; 22(12): 1037–45.

    Article  CAS  PubMed  Google Scholar 

  22. Brin MF, Lyons KE, Doucette J, Adler CH, Caviness JN, Comella CL, et al. A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor. Neurology. 2001; 56(11):1523–8.

    Article  CAS  PubMed  Google Scholar 

  23. Pahwa R, Lyons KE, Wilkinson SB, Simpson Jr RK, Ondo WG, Tarsy D, et al. Long-term evaluation of deep brain stimulation of the thalamus. J Neurosurg. 2006;104(4):506–12.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Barrow Neurological Institute, St. Joseph’s Hospital and Medical Center, Phoenix, AZ, USA

    Abraham N. Lieberman M.D.

  2. Department of Neurology, Banner Sunreach Research Institute, Sun City, AZ, USA

    Sara S. Dhanani M.D.

Authors
  1. Abraham N. Lieberman M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sara S. Dhanani M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Neurosurgery, SUNY Upstate Medical University, Syracuse, USA

    Lawrence S. Chin

  2. Dept. of Radiation Oncology, Univ. of Maryland School of Medicine, Baltimore, Maryland, USA

    William F. Regine

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Lieberman, A.N., Dhanani, S.S. (2015). Movement Disorders: Viewpoint—Medical Therapy. In: Chin, L., Regine, W. (eds) Principles and Practice of Stereotactic Radiosurgery. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8363-2_57

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-8363-2_57

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-8362-5

  • Online ISBN: 978-1-4614-8363-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation